Trial Profile
A real world, retrospective study evaluating 1-year clinical outcomes of patients who received treatment with the Resolute Onyx zotarolimus-eluting stent in China
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2017
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- 11 Aug 2017 New trial record